Bessiène Laura, Lombès Marc, Bouvattier Claire
Unité INSERM 1185, faculté de médecine Paris-Sud, 63, rue Gabriel-Péri, 94276 Le Kremlin-Bicêtre, France.
Unité INSERM 1185, faculté de médecine Paris-Sud, 63, rue Gabriel-Péri, 94276 Le Kremlin-Bicêtre, France; Service d'endocrinologie et de maladies de la reproduction, Assistance publique des hôpitaux de Paris, CHU de Bicêtre, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France.
Ann Endocrinol (Paris). 2018 Sep;79 Suppl 1:S22-S30. doi: 10.1016/S0003-4266(18)31235-6.
DSD for "Differences of Sex Development" or "Sexual Differences Development" refers to situations where chromosomal, gonadal or anatomical sex is atypical. DSD 46,XX are mainly represented by congenital adrenal hyperplasia (HCS) and are not a diagnostic issue. DSD 46,XY involve genes for the determination and differenciation of the bipotential gonad, making sometimes difficult the choice of sex at birth. They remain without diagnosis in about half of the cases, despite the new genetic techniques (exome, NGS). The management of DSD is complex as well as are the long-term consequences, particularly in terms of options for medical or surgical treatments, fertility and quality of life of patients that should be discussed. This review describes the main causes of DSD and the recent issues of their clinical management. It addresses the difficult question of identity of these patients, in a society that leaves no place for difference.
“性发育差异”(DSD)或“性别差异发育”是指染色体、性腺或解剖学性别不典型的情况。46,XX性发育差异主要由先天性肾上腺皮质增生(HCS)引起,并非诊断难题。46,XY性发育差异涉及双潜能性腺的决定和分化基因,有时会使出生时的性别选择变得困难。尽管有新的基因技术(外显子组、二代测序),约一半的病例仍无法确诊。性发育差异的管理很复杂,其长期后果也很复杂,特别是在医疗或手术治疗选择、生育能力以及患者生活质量等方面,这些都需要讨论。本综述描述了性发育差异的主要原因及其临床管理的最新问题。它探讨了在一个不容差异存在的社会中这些患者身份认同这一难题。